相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours
Kenneth Hsu et al.
CANCER GENE THERAPY (2021)
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity
Johannes C. Melms et al.
CANCER RESEARCH (2020)
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Andrew M. K. Law et al.
CELLS (2020)
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial
Kara L. Davis et al.
LANCET ONCOLOGY (2020)
Clinical development of therapies targeting TGF beta: current knowledge and future perspectives
D. Ciardiello et al.
ANNALS OF ONCOLOGY (2020)
HLA-G Neo-Expression on Tumors
Maria Loustau et al.
FRONTIERS IN IMMUNOLOGY (2020)
Stromal CCL2 Signaling Promotes Mammary Tumor Fibrosis through Recruitment of Myeloid-Lineage Cells
Genevra Kuziel et al.
CANCERS (2020)
Wnt/β-catenin-activated Ewing sarcoma cells promote the angiogenic switch
Allegra G. Hawkins et al.
JCI INSIGHT (2020)
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
Adilson Fonseca Teixeira et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma
Alexander Englisch et al.
PEDIATRIC BLOOD & CANCER (2020)
Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment
Jane Koo et al.
FRONTIERS IN ONCOLOGY (2020)
Turning the Tide Against Regulatory T Cells
SeongJun Han et al.
FRONTIERS IN ONCOLOGY (2019)
Emerging trends in immunotherapy for pediatric sarcomas
Kyle A. Dyson et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
Dana L. Casey et al.
FRONTIERS IN ONCOLOGY (2019)
Prognostic profiling of the immune cell microenvironment in Ewing?s Sarcoma Family of Tumors
David Stahl et al.
ONCOIMMUNOLOGY (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma
Reona Sakemura et al.
BLOOD (2019)
Immunotherapy in Pediatric Solid Tumors-A Systematic Review
Raoud Marayati et al.
CANCERS (2019)
Targeting chromatin complexes in fusion protein-driven malignancies
Gerard L. Brien et al.
NATURE REVIEWS CANCER (2019)
Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
Christian Spurny et al.
PEDIATRIC BLOOD & CANCER (2018)
Emerging Targeted and Immune-Based Therapies in Sarcoma
Seth M. Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G
Christian Spurny et al.
Oncotarget (2018)
Ewing sarcoma
Thomas G. P. Gruenewald et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
Nicholas L. Denton et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
Sareetha Kailayangiri et al.
ONCOIMMUNOLOGY (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
The prognostic importance of TGF-, TGF- receptor, and fascin in childhood solid tumors
Hikmet Gulsah Tanyildiz et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2017)
The neoepitope landscape in pediatric cancers
Ti-Cheng Chang et al.
GENOME MEDICINE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors
Vivek Verma et al.
FRONTIERS IN ONCOLOGY (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis
Xinru Zhou et al.
ONCOTARGET (2016)
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
Adrienne H. Long et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity
David Schirmer et al.
ONCOIMMUNOLOGY (2016)
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Pratistha Koirala et al.
SCIENTIFIC REPORTS (2016)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
IGF1R-and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
Xin Huang et al.
PLOS ONE (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
Hua Zhang et al.
BLOOD (2013)
Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging
L. Liebsch et al.
BRITISH JOURNAL OF CANCER (2013)
Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2
Hendrik W. van Deventer et al.
JOURNAL OF IMMUNOLOGY (2013)
The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
S. Kailayangiri et al.
BRITISH JOURNAL OF CANCER (2012)
EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors
Christopher H. Evans et al.
CLINICAL CANCER RESEARCH (2012)
Fibrocytes: emerging effector cells in chronic inflammation
Hong Peng et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Prognostic Significance of HLA Class I Expression in Ewing's Sarcoma Family of Tumors
Hiroki Yabe et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Fibrocytes: emerging effector cells in chronic inflammation
Ronald A. Reilkoff et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Distinct Types of Fibrocyte Can Differentiate from Mononuclear Cells in the Presence and Absence of Serum
S. John Curnow et al.
PLOS ONE (2010)
Fibrocyte activation in rheumatoid arthritis
Carole L. Galligan et al.
RHEUMATOLOGY (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
TGFβ signalling: a complex web in cancer progression
Hiroaki Ikushima et al.
NATURE REVIEWS CANCER (2010)
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Antje Moeller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease
Peter Brinkrolf et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β-dependent manner
John Andersson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
Responsiveness of fibrocytes to toll-like receptor danger signals
Carole Bahnelli et al.
IMMUNOBIOLOGY (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
L-arginine availability regulates T-lymphocyte cell-cycle progression
Paulo C. Rodriguez et al.
BLOOD (2007)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang et al.
CANCER RESEARCH (2006)
Nitric oxide in breast cancer: Induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis
Y Nakamura et al.
CLINICAL CANCER RESEARCH (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells
J Dairou et al.
FEBS LETTERS (2005)
Fibrocytes are potent stimulators of anti-virus cytotoxic T cells
C Balmelli et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
NA Marshall et al.
BLOOD (2004)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
RJ Phillips et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Ultrastructural and chromosomal studies on manganese superoxide dismutase in malignant mesothelioma
VL Kinnula et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells
M Viguier et al.
JOURNAL OF IMMUNOLOGY (2004)
Inhibition of MHC II gene transcription by nitric oxide and antioxidants
O Harari et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction
L Rivoltini et al.
IMMUNOLOGICAL REVIEWS (2002)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulation of T cell receptor CD3 chain expression by L-arginine
PC Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Reactive oxygen species as intracellular messengers during cell growth and differentiation
H Sauer et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2001)
HLA class I expression on human cancer cells - Implications for effective immunotherapy
BD Tait
HUMAN IMMUNOLOGY (2000)
分享论文
